Biotech Archives - Page 49 of 795

1 minute read

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity

May 1, 2:35 PM

United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.

UTHR

2 minute read

Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic

By Benzinga Neuro

May 1, 10:44 AM

The agency noted that in 2023, half of the new type 2 diabetes patients started their treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first.

NVO

2 minute read

Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations

By Vandana Singh

May 1, 10:38 AM

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for direct-to-consumer online platform.

LLY

2 minute read

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook

By Vandana Singh

May 1, 9:42 AM

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix. Expectations soar with raised 2024 EPS and sales forecasts.

BNTX

1 minute read

Integra LifeSciences To Spotlight CereLink Intracranial Pressure Monitoring System At The American Association Of Neurological Surgeons Annual Scientific Meeting

By Benzinga Newsdesk

April 30, 5:27 PM

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink® ICP Monitoring System,

IART

1 minute read

Predictive Oncology Announces Progress With FluGen In the Development Of First-Of-Its-Kind Intranasal Flu Vaccine, As Part Of A $6.2M Phase 2B Grant Awarded By The U.S. DOD

By Benzinga Newsdesk

April 30, 4:44 PM

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluGen to bring a first-of-its-kind intranasal flu vaccine to market, as part of a $6.2

POAI

3 minute read

“Schumer Says DEA Marijuana Rescheduling Decision Is ‘Historic,’ But He Remains ‘Strongly Committed’ To Passing Banking And Legalization Bills” – Marijuana Moment

By Benzinga Newsdesk

April 30, 4:43 PM

https://www.marijuanamoment.net/schumer-says-dea-marijuana-rescheduling-decision-is-historic-but-he-remains-strongly-committed-to-passing-banking-and-legalization-bills/Senate Majority Leader Chuck Schumer (D-NY) says

ACB

4 minute read

SCYNEXIS Presented Preclinical Data On Second Generation Fungerp SCY-247 At The Congress Of The European Society Of Clinical Microbiology And Infectious Diseases

By Benzinga Newsdesk

April 30, 4:39 PM

In vivo data demonstrated efficacy of SCY-247 in mouse model of invasive candidiasis caused by Candida glabrata SCY-247 showed in vitro activity against a broad range of pathogenic fungi, including azole-resistant

SCYX

2 minute read

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market

By Piero Cingari

April 30, 4:38 PM

Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline.

AAUKF

2 minute read

Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs

By Vandana Singh

April 30, 3:11 PM

Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies discussed.

LLY